Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Palandri

Showing results (31-40 of 187) with videos related to

Pageof 19
Sort By:
Heliyon|February 27, 2023
Sustained response off therapy after fostamatinib: A chronic refractory ITP case reportGiuseppe Auteri, Mattia Biondo, Camilla Mazzoni, et al.
Research and Practice in Thrombosis and Haemostasis|December 23, 2021
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodiesFrancesca Palandri, Christian Di Pietro, Francesca Ricci, et al.
British Journal of Haematology|November 9, 2018
Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patientsFrancesca Palandri, Lucia Catani, Giuseppe Auteri, et al.
Mediators of Inflammation|September 28, 2016
Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and SplenomegalyDaria Sollazzo, Dorian Forte, Nicola Polverelli, et al.
Haematologica|July 18, 2009
Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failureFrancesca Palandri, Fausto Castagnetti, Simona Soverini, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or IntoleranceMassimo Breccia, Francesca Palandri, Paola Guglielmelli, et al.
Journal of Ultrasound|July 26, 2024
Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosisVito Sansone, Giuseppe Auteri, Francesco Tovoli, et al.
Annals of Hematology|February 23, 2018
Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatmentMassimo Breccia, Francesca Palandri, Luigiana Luciano, et al.
Annals of Hematology|September 1, 2012
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopeniaLucia Catani, Daria Sollazzo, Sara Trabanelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2023
Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter StudyGiuseppe Auteri, Simona Paglia, Camilla Mazzoni, et al.
Pageof 19

Showing results (31-40 of 187) with videos related to

Sort By:
Pageof 19
Heliyon|February 27, 2023
Sustained response off therapy after fostamatinib: A chronic refractory ITP case reportGiuseppe Auteri, Mattia Biondo, Camilla Mazzoni, et al.
Research and Practice in Thrombosis and Haemostasis|December 23, 2021
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS-13 activity and autoantibodiesFrancesca Palandri, Christian Di Pietro, Francesca Ricci, et al.
British Journal of Haematology|November 9, 2018
Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patientsFrancesca Palandri, Lucia Catani, Giuseppe Auteri, et al.
Mediators of Inflammation|September 28, 2016
Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and SplenomegalyDaria Sollazzo, Dorian Forte, Nicola Polverelli, et al.
Haematologica|July 18, 2009
Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failureFrancesca Palandri, Fausto Castagnetti, Simona Soverini, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or IntoleranceMassimo Breccia, Francesca Palandri, Paola Guglielmelli, et al.
Journal of Ultrasound|July 26, 2024
Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosisVito Sansone, Giuseppe Auteri, Francesco Tovoli, et al.
Annals of Hematology|February 23, 2018
Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatmentMassimo Breccia, Francesca Palandri, Luigiana Luciano, et al.
Annals of Hematology|September 1, 2012
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopeniaLucia Catani, Daria Sollazzo, Sara Trabanelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2023
Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter StudyGiuseppe Auteri, Simona Paglia, Camilla Mazzoni, et al.
Pageof 19